Proton Therapy Publication Proton Therapy Publication
Menu

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.

April 2021
Executive summary

This MD Anderson study published in the Green Journal retrospectively compares patients with oropharyngeal cancer (OPC) who received IMRT (n = 429) and IMPT (n = 103).

With a median follow-up time of 36.2 months, the study reported that the moderate-severe xerostomia was less common in the IMPT group than in the IMRT group at 18-24 months (6% vs. 20%; p = 0.025) and 24-36 months (6% vs. 20%; p = 0.01).

Key content topics
IMPT
IMRT

Other popular content

Proton Therapy Publication
Proton therapy publication
October 2021
Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
Bicentric Treatment Outcomes following PT for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
Link to the fully detailed content